Liraglutide (Saxenda / Victoza) vs Retatrutide
Both are used for lose fat. Here's how they compare on human evidence, mechanism, safety and availability — in plain English.
| Liraglutide (Saxenda / Victoza) | Retatrutide | |
|---|---|---|
| Human evidence | ★★★★☆ | ★★★★☆ |
| Legal status | Prescription | Not Approved |
| How it works | Daily short-acting GLP1R agonist — the first-generation version of semaglutide's mechanism. | First-in-class triple agonist — GLP1R + GIPR + glucagon receptor (GCGR). Adding glucagon-receptor agonism raises energy expenditure and hepatic fat oxidation on top of the twin appetite pathways. |
| In plain English | The older, daily-injection GLP-1. Works, but weaker than weekly semaglutide and needs a daily shot. | Three metabolic switches in one molecule — two cut hunger, the third turns up calorie-burning. In the Phase 3 TRIUMPH-4 trial (Dec 2025) it produced 28.7% weight loss at 68 weeks — the largest ever for a drug. Not yet approved. |
| Bottom line | Largely superseded by weekly agents. | The likely next leader once approved. Source: Lilly TRIUMPH-4 release. |
| Availability | Prescription only | Not widely approved |
Which is better for lose fat?
Both carry a comparable human-evidence rating (★★★★☆). Choose on mechanism fit, side-effects, availability and cost rather than evidence strength alone — they work through different mechanisms.
Full breakdowns: Liraglutide (Saxenda / Victoza) · Retatrutide.
Common questions
Is Liraglutide (Saxenda / Victoza) or Retatrutide better for lose fat?
Both carry a comparable human-evidence rating (★★★★☆). Choose on mechanism fit, side-effects, availability and cost rather than evidence strength alone — they work through different mechanisms.
What's the difference between Liraglutide (Saxenda / Victoza) and Retatrutide?
Liraglutide (Saxenda / Victoza): Largely superseded by weekly agents. — Retatrutide: The likely next leader once approved. Source: Lilly TRIUMPH-4 release.